Summary Safety Review - Proton Pump Inhibitors (PPIs) - Assessing the risk of...
Health Canada reviewed the potential risk of a type of skin reaction known as subacute cutaneous lupus erythematosus(SCLE) with the use of PPIs after a published article that found these drugs may contribute to the reaction.
Organization:
Health Canada
Resource Formats:
- HTML